December 18, 2024
On stage of the 20th edition of the Dutch Life Sciences conference, Stijn Heessen, COO of Alder Therapeutics became the proud winner of the Investors Forum and was awarded a partnering ticket with a total value of €2,500 and a half day Booster Session offered by PwC.
December 17, 2024
Take a look at which presentations are available to be downloaded.
December 16, 2024
Explore the transformative power of automation in advanced therapy production at the Dutch ATMP Summit on March 12th, 2025 at Corpus in Leiden.
December 13, 2024
The winner of the Venture Challenge was announced today at the Dutch Life Sciences Conference. The proud winner of the 2024 fall edition is Sniper Therapeutics! The innovative venture is developing a new T-cell based therapy for Diffuse Midline Glioma (DMG), which is an aggressive and incurable pediatric brain tumor.
December 12, 2024
A one-day course on January 24, 2025 for startups active in the Medical technology sector.
December 11, 2024
The Investors forum offers an exciting opportunity for young companies looking for equity capital and/or partnerships. Many promising start-ups applied for this year's forum and following the recent presentation of their test pitches to the jury, 12 selected companies are getting ready to deliver their pitch during the Investors forum breakfast and lunch sessions tomorrow.
November 04, 2024
Six teams have started the Venture Challenge Fall 2024! Between These starting life sciences entrepreneurs will learn everything about building and pitching a business plan.
October 18, 2024
We have received many applications from young companies wishing to pitch at the DLSC conference.